 Angiopoietin-2 has been proposed as a biomarker in different cancer types.Angiopoietin-2 expression levels are proportional to the cancer stage for both small and non-small cell lung cancers.It has been also implicated to play role in hepatocellular and endometrial carcinoma-induced angiogenesis.